The U.S. Food and Drug Administration approved the obesity drug Wegovy for people with the chronic liver disease known as MASH and severe fibrosis.

Eli Lilly's new oral GLP-1 medication orforglipron produced an average weight loss of 12.4% (27.3 pounds) in clinical trials.

For the last four years, women in Hawaiʻi have been able to instead get mifepristone through the mail or at some pharmacies.

Children were reportedly hospitalized after starting treatment. Scorpion Capital suggests Soleno's medication could face ...

Ozempic may have serious side effects, including thyroid cancer and problems with the pancreas, gallbladder, kidneys, and ...

Immigration attorneys and advocates are raising concerns about what they say are inhumane conditions at the "Alligator ...

A recent probe into state records and local inspection documentation related to Gabriel House -- the site of a fatal July 13 ...

Erin Kelly, from Queensland, Australia, recently learned she had the disease after inheriting a rare genetic mutation called ...

A restful night’s sleep is vital to a healthy lifestyle but an Indiana physician said most Americans are not getting enough ...

Costco has announced that it will not sell mifepristone abortion pills at its U.S. pharmacies, citing a lack of consumer ...

A large new study found that the nonprescription Opill is expanding birth control access to many women who used no contraception in the past.

The DEA says fentanyl is unlike any drug threat the country has faced before. It’s often mixed into counterfeit pills, ...